Scott Koenig - 15 Feb 2026 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
15 Feb 2026
Net transactions value
$0
Form type
4
Filing time
17 Feb 2026, 18:22:16 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Koenig Scott Director 9704 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Beth A. Smith, Attorney-in-fact 17 Feb 2026 0001587514

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +21,165 +2.5% $0.000000 867,240 15 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -21,165 -100% $0.000000 0 15 Feb 2026 Common Stock 21,165 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.